⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
HiveMQ Launches Platform to Turn Real-Time Manufacturing Plant Data into Operational Intelligence
prnewswire.com
LLY
Aktis Oncology to Present at Upcoming September Investor Conferences
globenewswire.com
LLY
Luma Group Successfully Closes LumaBio Fund I at $410 Million
prnewswire.com
LLY
CURE ALZHEIMER'S FUND EXPANDS ITS SCIENTIFIC ADVISORY BOARD
prnewswire.com
LLY
Chronic Lower Back Pain Market Forecast, 2036 | Industry Set for Steady Growth as Regenerative Medicine and Opioid Alternatives Drive Innovation
globenewswire.com
LLY
VRTX
MESO
2026 Obstructive Sleep Apnea (OSA) Competitive Landscape and Clinical Trial Analysis - 18+ Companies Advance New OSA Therapies
globenewswire.com
LLY
APMD
AMGN
NVO
Form 8-K
sec.gov
SGMOQ
LLY
ContentCon 2026: Every Brand Now Has Two Audiences, Humans and Agents
globenewswire.com
ALGT
PHG
MASS
WMT
MDLZ
SSTK
SMCI
NVDA
MSFT
GOOG
AMZN
META
IBM
CRM
ADBE
INTC
AMD
MU
QCOM
PANW
SNPS
CDNS
ASML
AMAT
LRCX
KLAC
TER
NXPI
ON
AEHR
PLTR
AI
UPST
SOFI
COIN
MARA
RIOT
PLUG
FCEL
BE
EXAS
REGN
GILD
BIIB
CRSP
ROKU
NFLX
DIS
CMCSA
TTD
SNOW
DDOG
ZS
CRWD
OKTA
SMTC
MCHP
ADI
TXN
MRVL
ALGN
CTAS
PAYX
ADP
CVS
UNH
AMGN
LLY
PFE
MRK
JNJ
BMY
ABBV
VRTX
AZN
NVO
SNY
XOM
CVX
SRE
NEE
DUK
SO
PCG
ED
AEP
ETR
WEC
D
NI
EXC
NRG
CEG
IRBT
GOOGL
4BIO Capital leads oversubscribed $33 Million Seed Financing of Cloverleaf Bio, Advancing Novel RNA-Based Cancer Therapeutics
globenewswire.com
ABBV
LLY
Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer Therapeutics
globenewswire.com
ABBV
LLY